Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17

1.

Mineralisation defects with pamidronate therapy for Paget's disease.

Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT, Boyce BF.

Lancet. 1993 Dec 11;342(8885):1459-60.

PMID:
7902484
3.

A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.

Abelson A.

Curr Med Res Opin. 2008 Mar;24(3):695-705. doi: 10.1185/030079908X260899. Epub 2008 Jan 25. Review.

PMID:
18226324
4.

Efficacy and safety of drugs for Paget's disease of bone.

Reginster JY, Lecart MP.

Bone. 1995 Nov;17(5 Suppl):485S-488S. Review.

PMID:
8573423
5.

Tiludronate. A new treatment for an old ailment: Paget's disease of bone.

Morales-Piga A.

Expert Opin Pharmacother. 1999 Nov;1(1):157-70. Review.

PMID:
11249559
6.

Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Fitton A, McTavish D.

Drugs. 1991 Feb;41(2):289-318. Review. Erratum in: Drugs 1992 Feb;43(2):145.

PMID:
1709854
7.

Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.

Polyzos SA, Anastasilakis AD, Makras P, Terpos E.

Exp Clin Endocrinol Diabetes. 2011 Oct;119(9):519-24. doi: 10.1055/s-0031-1284365. Epub 2011 Aug 2. Review.

PMID:
21811962
8.

Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.

Cundy T, Wheadon L, King A.

J Bone Miner Res. 2004 May;19(5):703-11. Epub 2004 Jan 19. Review.

9.

Perspectives: a practical guide to the use of pamidronate in the treatment of Paget's disease.

Siris ES.

J Bone Miner Res. 1994 Mar;9(3):303-4. Review. No abstract available.

PMID:
8191921
10.

Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.

Keating GM, Scott LJ.

Drugs. 2007;67(5):793-804. Review.

PMID:
17385948
11.

[Paget's disease and its therapeutic management].

Orcel P, Rousière M.

Presse Med. 2005 Apr 23;34(8):612-6. Review. French.

PMID:
15962504
12.

Pamidronate in the treatment of Paget's disease.

Selby PL.

Bone. 1999 May;24(5 Suppl):57S-58S. Review. No abstract available.

PMID:
10321930
13.

Medical management of Paget's disease of bone: indications for treatment and review of current therapies.

Siris ES, Lyles KW, Singer FR, Meunier PJ.

J Bone Miner Res. 2006 Dec;21 Suppl 2:P94-8. Review.

14.

Paget's disease of bone: diagnosis and management.

Kanis JA, Evanson JM, Russell RG.

Metab Bone Dis Relat Res. 1981;3(4-5):219-30. Review.

PMID:
6220190
15.

Paget's disease of bone: diagnosis and treatment update.

Noor M, Shoback D.

Curr Rheumatol Rep. 2000 Feb;2(1):67-73. Review.

PMID:
11123042
16.

Zoledronic acid for Paget's disease of bone.

Maricic M.

Drugs Today (Barc). 2007 Dec;43(12):879-85. doi: 10.1358/dot.2007.43.12.1141564. Review.

PMID:
18174973
17.

Paget's disease of bone: clinical, pathogenetic and therapeutic aspects.

Papapoulos SE.

Baillieres Clin Endocrinol Metab. 1997 Apr;11(1):117-43. Review.

PMID:
9222489
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk